What would you do if you were a parent with a child suffering from Juvenile Rheumatoid Arthritis? Unfortunately there are limited options for treatment of children with this disease. Despite Celebrex’s well-documented link to higher heart risks, Pfizer Inc. wants permission to sell its painkiller to treat children as young as 2 who have arthritis.

A recent vote from the FDA Arthritis Advisory Committee recommended that Pfizer Inc. be allowed to market the painkiller Celebrex as a treatment...